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Purpose: Robotic assisted radical prostatectomy (RARP) presents challenges for the 
surgeon, especially during the initial learning curve. We aimed to evaluate early and 
mid-term functional outcomes and complications related to vesicourethral anastomo-
sis (VUA), in patients who underwent RARP, during the initial experience in an aca-
demic hospital. We also assessed possible predictors of postoperative incontinence and 
compared these results with the literature.
Materials and Methods: We prospectively collected data from consecutive patients that 
underwent RARP. Patients with at least 6 months of follow-up were included in the 
analysis for the following outcomes: time to complete VUA, continence and complica-
tions related to anastomosis. Nerve-sparing status, age, BMI, EBL, pathological tumor 
staging, and prostate size were evaluated as possible factors predicting early and mid-
term continence. Results were compared with current literature.
Results: Data from 60 patients was assessed. Mean time to complete VUA was 34 min-
utes, and console time was 247 minutes. Continence in 6 months was 90%. Incidence 
of urinary leakage was 3.3%, no patients developed bladder neck contracture or post-
operative urinary retention. On multivariate analysis, age and pathological staging was 
associated to 3-month continence status.
Conclusion: Our data show that, during early experience with RARP in a public uni-
versity hospital, it is possible to achieve good results regarding continence and other 
outcomes related to VUA. We also found that age and pathological staging was associ-
ated to early continence status.
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InTRODucTIOn
Radical prostatectomy (RP) is the standard 
surgical therapy for localized prostate cancer, which 
is the second most common solid neoplasm in men 
worldwide and the fourth cause of cancer death (1). 
In Brazil, it occupies the first position regarding in-
cidence of cancer in men, and it is the second cause 
of mortality (2).
 Robotic assisted radical prostatectomy 
(RARP) has become the most commonly performed 
surgical technique in several countries, and is incre-
asingly being employed in Brazil (3). Advocated ad-
vantages of robotic surgery are decreased blood loss 
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and other complications, better early continence 
and sexual function, less positive surgical margins, 
and also diminished hospital stay and early return 
to regular activities (4-6).
 Some technical features of the robotic sys-
tem as the three-dimensional image with magni-
fication, wristed instrumentation, and prevention 
of biological tremor may help on performing the 
challenging steps of RARP like bladder neck and 
neurovascular bundle dissection and vesicourethral 
anastomosis (VUA). Among those, VUA is one of 
the most technically demanding since it requires a 
watertight, tension-free suture, and minimal tissue 
damage, in order to obtain adequate healing. Even 
when performed with robotic assistance, an inade-
quate anastomosis may result in major complica-
tions like urinary leakage, prolonged urethral ca-
theterization, increased length of stay, incontinence 
and bladder neck sclerosis (7). Overall complication 
rates with RARP may reach approximately 1.5% to 
17.8%, even after the learning curve (8).
 Although it is already widespread in the 
United States and Europe, RARP is still under 
implementation in several centers in Brazil and 
other countries, therefore we believed that it is 
crucial to evaluate results and complications du-
ring our early experience.
 Considering the above mentioned, and sin-
ce there is still few published data originated from 
robotic programs in our country, our objective was 
to assess early and mid-term functional outcomes 
and complications related to VUA, and to evaluate 
possible predictors of continence, in patients who 
underwent RARP during the initial experience in 
an academic hospital. We also compared these re-
sults with the literature.
MATERIALs AnD METhODs
 We conducted a prospective study from 
August 2013 to August 2015 in the urology depart-
ment at Hospital de Clínicas de Porto Alegre (Porto 
Alegre, RS, Brazil).
 Patients with clinically localized prostate 
cancer who were candidate to primary treatment 
were offered RARP. Data was collected prospec-
tively from consecutive patients, and those with 
at least 6 months of follow-up were included in 
the study. Operations were performed by two sur-
geons using the da Vinci SI robotic system with 
dual console. A total of 63 patients were submit-
ted to RARP and VUA using monofilament barbed 
suture. The first 24 cases were mentored by an 
expert robotic surgeon.
surgical Technique
 Radical prostatectomy was performed 
transperitoneally in the following sequence: dis-
section of Retzius space, dorsal venous complex 
ligation, bladder neck incision, vas deferens liga-
tion, seminal vesicles dissection, lateral prostatic 
pedicles and antegrade nerve bundle dissection, 
apical dissection and pelvic lymph node dissection 
(PLND), when indicated. We use a four-arm ro-
botic approach for port placement, with the third 
working robotic arm positioned on the right and 
one assistant port on the left flank, as described by 
Chopra and colleagues (9). After completion of RP 
and PLND, posterior reconstruction with a modi-
fied Rocco Stitch (RS) and VUA were performed 
according to Van Velthoven’s technique (10, 11). A 
18F Foley catheter was left usually for 7 days.
 RS and VUA were performed using V-
-LOCTM 90 3-0 CV-23 (17mm needle) or V-20 
(26mm needle), depending on surgeon’s preferen-
ce. At the end of surgery a 15F Blake drain was 
placed in the pelvis through the right (3rd arm) 
robotic trocar.
Outcome Measures
 Data was collected prospectively using 
standardized institutional protocol. Preoperative, 
demographic and postoperative data were recorded.
 Surgical outcomes were time to perform 
both the RS and VUA individually. Also, intra-
operative events related to suture material were 
recorded (suture breakage, shearing of urethra 
or bladder neck, loss of tension). Operative times 
were recorded by stopwatch during video playba-
ck of all cases. The VUA time was measured from 
the first bite on the bladder until confirmation of 
a watertight VUA, by filling of the bladder with 
120mL of saline. Estimated blood loss (EBL) and 
transfusion rates were also recorded, since blee-
ding during or after surgery has been suggested to 
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negatively affect the quality of anastomosis and 
to be a predictor of urinary leakage (12).
 Early postoperative complications were de-
fined. Urinary leakage was considered as persistent 
drainage (more than 2 days) from drain or surgical 
incision, confirmed by elevation of creatinine in 
the fluid, or by contrast cystography. Cystography 
was not routinely used. Incidence of ileus was also 
presented and it was defined as requiring nasogas-
tric tube placement as a result of an inability to 
resume a normal diet.
 During follow-up, mid-term outcomes were 
evaluated prospectively during clinic visits. Urina-
ry retention requiring catheterization, bladder neck 
sclerosis and continence were recorded.
 Continence was assessed by phone calls or 
during visits to clinic on months 1, 3 and 6, by 
asking patients for need and number of pads used 
per day.
 Possible predictors of continence were eva-
luated. Nerve-sparing status, age, BMI, EBL, pa-
thological tumor staging, and prostate size were 
included as possible influencing factors and were 
compared to continence at 1, 3 and 6 months. Pros-
tate size was derived from TRUS or MRI studies. 
Clinical and pathological stages were reported ac-
cording to the 2009 TNM system and subcategori-
zed into two groups: localized (pT2) or locally ad-
vanced disease (pT3 and pT4).
 Nerve-sparing status was recorded pros-
pectively according to surgeon’s subjective assess-
ment after surgery, or during video playback. Gra-
ding was defined for each neurovascular bundle as: 
non-nerve sparing, partial nerve-sparing or total 
nerve-sparing. For statistical analysis patients were 
subcategorized into two groups of preservation: at 
least 1 bundle totally spared or neither bundle spa-
red.
 Baseline characteristics and outcomes of 
all patients are presented as median (interquartile 
range) or mean (standard deviation) for continuous 
variables and frequencies and percentages for ca-
tegorical variables. Logistic regression was used 
for univariate and multivariate analyses. A level of 
statistical significance of p<0.25 was considered for 
including variables on a final multivariate model 
for predictors of incontinence. Reported p values 
were 2-sided and statistical significance was set at 
p<0.05 on multivariate logistic regression. All sta-
tistical tests were performed using SPSSv.18 (IBM 
Corp, Armonk, NY).
 The procedure with its benefits and all pos-
sible complications was explained to the patients 
and all participants signed a written consent. The 
study was approved by the Local and National 
Ethics and Research Committee.
REsuLTs
 A total of 63 patients were consecutively 
submitted to RARP during the described period. 
Three patients were excluded from the analysis, two 
because they were operated by visiting surgeons 
from other institutions, and one because VUA was 
performed using monofilament non-barbed suture. 
Two patients had previous transurethral resection 
of the prostate. Sixty patients were included in the 
final analysis.
 Median patient age was 64 (interquartile 
range 62–70). Median BMI value was 26.2 (23.8–
29.2). Median baseline PSA value was 6.3ng/mL 
(5–8.2). The clinical stage of the primary tumor was 
cT1c in 28 (47%) patients, cT2a in 13 (22%) pa-
tients, cT2b in 4 (7%) patients, cT2c in 14 (23%) 
patients, and cT3 in 1 (2%) patient. Preoperative 
demographics of patients are summarized in Ta-
ble-1. Table-2 shows postoperative pathological 
tumor staging.
 The perioperative outcomes are summari-
zed in Table-3. Mean time to complete VUA was 
34 minutes, and to complete RS median time was 
8 minutes. The mean total procedure duration and 
console time was 298, and 247 minutes respecti-
vely. Mean EBL was 95mL (±158). No patients had 
blood transfusions during surgery, but two had pos-
toperative bleeding requiring transfusion. Patients 
maintained Foley catheter for a median period of 7 
days.
 There were no relevant intraoperative 
events regarding suture material adequacy. We did 
not observe shearing of tissues, back slippage or 
suture breakage.
 Regarding early and mid-term compli-
cations, two patients (3.3%) were diagnosed with 
urinary leakage, both of them treated conservati-
vely without need for surgical reintervention. Ileus 
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requiring nasogastric drainage occurred in 3 (5%) 
patients, and these were not the same patients that 
presented urinary leakage (Table-4). With an ave-
rage follow-up of 18.6 (±8.2) months, no patients 
have developed bladder neck contracture.
 Table-5 shows our continence results. Con-
tinence (defined as no pad use or only one safe-
ty pad) was 62.1%, 76.7% and 90% in 30 days, 3 
months and 6 months respectively. When consi-
dering continent patients only those that reported 
using zero pads, our 6-month result was 78.3%.
 We have assessed continence results at 
months 1, 3 and 6 regarding possible predic-
tors. Incontinent patients (1 or more pads used 
per day) at 3 and 6 months of follow-up were 
Table 3 - perioperative outcomes.
Variable n = 60
Total procedure time (min) 298±73
Console time (min) 247±65
Rocco Stitch time (min) 8±6
VUA time (min) 34±16
Estimated blood loss (mL) 95.7±158
Transfusions (n, %) 2 (3.3%)
Length of stay (days) 3 (2-5)
Catheter duration (days) 7 (7-10)
J-Blake drain duration (days) 3 (2-3)
Mean±standard deviation; Median (interquartile range)
Table 1 - patients’ demographics. 
n = 60
Age, years 64 (62–70)
BMI 26.2 (23.8–29.2)
Preoperative PSA, ng/mL 6.3 (5–8.2)
clinical T stage (n, %)
cT1c 28 (47%)
cT2a 13 (22%)
cT2b 4 (7%)
cT2c 14 (23%)
cT3a/b 1 (2%)
Gleason score Biopsy (n, %)
6 27 (45%)
7 (3+4) 21 (35%)
7 (4+3) 7 (11.7%)
8 4 (6.7%)
9 1 (1.7%)
prostate size at TRus (median; range) 35.5 (28.1 – 46.1)
median (interquartile range); TRus: transrectal ultrasound
Table 2 - postoperative pathological staging.
n=60
Pathological Staging; n (%) pT2a 10 (16.7%)
pT2b 7 (11.7%)
pT2c 33 (55%)
pT3a 4 (6.7%)
pT3b 5 (8.3%)
pT4 1 (1.7%)
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significantly older at univariate analysis. Table-6 
shows these comparisons at 3 months of follow-
-up. For other variables, there was no statistically 
significant association.
 Table-7 shows adjusted odds ratios esti-
mated from a model of univariate logistic regres-
sion. The variables with p-value <0.25 were in-
cluded on the multiple logistic regression model, 
where older age (p=0.02) and higher pathological 
staging (p=0.04) were associated to incontinence 
at 3 months. All the other clinical and patholo-
gical characteristics (nerve-sparing status, esti-
mated blood loss, BMI and prostate size) were 
similar between groups at 3 months. There was 
no association of factors with continence at first 
and sixth months post-operative. Nerve sparing 
technique did not affect continence status in this 
series of patients.
DIscussIOn
 In the present study we analyzed the perio-
perative, short and mid-term outcomes and com-
plications related to VUA during learning curve 
of RARP and compared them with the literature. 
To our knowledge this is the first study presenting 
early experience with RARP in a public university 
hospital in Brazil.
 Previous reports showing results from le-
arning curve have suggested an increased rate of 
complications, and that important outcomes as 
blood loss and positive margin status would im-
prove after 100 or 250 cases, suggesting a steep 
learning curve (13). The number of surgical cases 
needed to achieve a low rate of complications re-
lated to the anastomosis is not clearly defined. In 
a single surgeon series, Ou et al. showed that the 
learning curve for significantly decreasing overall 
complications was 150 cases (14).
 In Brazil, a few published studies have re-
ported experiences with RARP, and none of them 
focused on VUA outcomes and complications. The 
first published paper discussing RARP in Brazil was 
in 2009 by Colombo Jr and from a private hospital. 
Results from these series are discussed here.
 Several factors influence VUA quality 
and one of them is the type of suture material. 
Recently, two meta-analysis comparing barbed 
sutures (BS) to conventional monofilament sutu-
res for VUA indicated shorter anastomosis time, 
operative time, and equivalent postoperative le-
akage rate, estimated blood loss, length of stay, 
and continence rates (15, 16). The authors dee-
med that it is easier doing the VUA with BS than 
with conventional sutures, and concluded that it 
is an important consideration especially for the 
novice surgeon (16).
 Another factor that may influence con-
tinence and complications related to VUA is the 
type of reconstruction performed. Recent studies 
have suggested that a more complex posterior and 
anterior reconstruction of the peri-urethral struc-
Table 4 - complications related to vuA.
Complications n (%)
Urinary Leakage 2 (3.3%)
Ileus 3 (5%)
Urinary Retention 0
Bladder Neck Contracture 0
Table 5 - funcional outcome.
Urinary continence over time 
(pads/day)
N, N {missing}
1 month 58 {2}
0 26 (44.8%)
1 10 (17.2%)
0-1 36 (62.1%)
2 10 (17.2%)
>2 12 (20.7%)
3 months 60 {0}
0 39 (65%)
1 7 (11.7%0
0-1 46 (76.7%)
2 8 (13.3%)
>2 6 (10%)
6 months 60 {0}
0 47 (78.3%)
1 7 (11.7%)
0-1 54 (90%)
2 4 (6.7%)
>2 2 (3.3%)
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tures could improve early continence with a low 
incidence of complications (17, 18). The quality of 
nerve-sparing has also shown to influence posto-
perative continence (19).
During their early experience, Artibani et 
al. reported mean blood loss of 400mL, with 9.8% 
of the patients receiving blood transfusions (20). 
In the first reported series in Brazil, Colombo Jr 
et al. reported mean estimated bleeding of 480mL 
(100–1800) and transfusion necessary in two 
patients (2%). One study from Tobias-Machado 
and another from Lott found mean blood loss of 
245.6mL and 212mL respectively (21, 22). In our 
series, mean EBL was 95mL (±158), no patients 
had blood transfusions during surgery, but two 
(3.3%) required it during postoperative period.
Regarding operative times in initial expe-
rience series, surgical duration reported in previous 
studies is extremely variable. One study that eva-
luated the first 100 cases in a secondary hospital, 
showed mean VUA time of 47.9 min. and mean 
console operative times of 225 min. (23). Reports 
from initial series in some high volume centers 
showed median surgical duration from 215 to 274 
minutes (24, 25). Series from our country repor-
ted mean or median surgical times from 175 to 
298 minutes (3, 21, 22, 26). In 2005 Patel et al. 
described an extremely short mean operative time 
of 141 min. in their initial 200 cases (27). In the 
present series, mean total console time, and time 
to perform anastomosis, were 298 and 34 minutes 
respectively.
Our study presents results from our initial 
experience with RARP in a laparoscopic naive 
center. During these procedures, lessening surgi-
cal time was not a main goal compared to achie-
Table 7 - Logistic regression analyses of 3-month urinary continence factors.
 Univariate Multivariate
Factor P OR 95% CI P OR 95% CI
Age 0.03 1.12 1.01 1.25 0.02 1.13 1.02 1.28
Prostate size 0.48 0.98 0.95 1.02
BMI 0.99 0.99 0.85 1.16
EBL 0.57 0.99 0.99 1.00
Pathological staging 0.06 3.4 0.93 13.29 0.04 4.58 1.12 21.67
Nerve sparing status 0.33 1.74 0.56 5.47
BMI = body mass index; EBL = estimated blood loss
Table 6 - comparison of factors according to continence status 3-months.
  Univariate
Factor  Continent (n= 39) Incontinent (n=21) P
Age  61.93 (5.16) 65.39 (6.57) 0.028
Prostate size 42.48 (18.57) 37.67 (24.56) 0.491
IMC 26.43 (3.70) 26.41 (3.50) 0.991
EBL  104.1 (167.03) 80 (143.49) 0.578
Pathological staging
pT2 34 (87.2%) 14 (66.7%) 0.12
pT3–pT4 5 (12.8%) 7 (33.3%)
nvB preservation
Total 22 (61.1%) 9 (47.4%) 0.489
non-total 14 (38.9%) 10 (52.6%)
BMI = body mass index; EBL = estimated blood loss; nvB = neurovascular bundle
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ving good functional and oncological results. This 
reflected on our times of whole surgery and time 
to complete anastomosis being longer than cur-
rent series of experienced surgeons, but allowed a 
very low incidence of complications related to the 
anastomosis, with no bladder neck sclerosis, no 
retention, and only 2 urinary leakage that did not 
require any intervention for its treatment. Ano-
ther factor influencing total operative time is that 
most patients (65%) required pelvic lymph node 
dissection. We usually perform standard or exten-
ded PLND on patients with intermediate or high 
risk of progression, respectively.
 Regarding these mid-term complications 
our results were also comparable to current lite-
rature. In 2008, Artibani and colleagues published 
their initial 41 cases and described one bladder-
-urethra anastomosis dehiscence, which required 
reintervention, and one bladder-urethra anasto-
mosis stenosis using monofilament suture (20). Re-
cently Jacobsen et al. reported their data from 236 
consecutive patients, with an anastomotic leakage 
frequency of 2.9%, and anastomotic stricture of 
4.9% (28). In another study that assessed compli-
cations during early experience of RARP, among 
322 patients, urine leakage developed in 24 (7.5%) 
and anastomotic strictures requiring transurethral 
incision developed in 2 cases (0.3%) (29). One study 
that evaluated first 100 cases performed by 5 sur-
geons in a private hospital in Brazil, reported zero 
cases of leakage or bladder neck contraction (3).
 Together with a low incidence of compli-
cations and apart from longer operative times than 
other series, our continence results were compara-
ble to current literature. Publications from high-
-volume centers have found rates of continence 
(up to 1 pad/day) at 6 months of 71.7% to 93% on 
initial series (24, 30). One report from Brazil found 
6 months continence rates of 93.3% (21). Lott et 
al. described continence rates of 88% in 6 months 
(22). Considering the criterion of continence up to 
1 security pad, the present series showed 90% con-
tinence at 6 months.
 Regarding factors predictive of return to 
continence, we found that patient age and pa-
thological staging were significantly associated 
with 3-month continence status on multivaria-
ble analysis.
 Patient age and Charlson comorbidity in-
dex have been found to be significantly associated 
with 12-month continence status after RARP in 
previous studies (31). Higher quality nerve-sparing 
was found to be associated positively with 1 year 
continence and to patients’ perception of urinary 
recovery as measured by EPIC urinary outcome 
scores (19, 32).
 Possible reasons for not finding a statisti-
cally significant association between the degree of 
preservation of neurovascular bundles and urinary 
incontinence are our sample size, lack of standar-
dized score for the degree of preservation and lack 
of data on 12 months continence. Other factors 
that might affect continence outcomes were not 
included in our study such as bladder neck preser-
vation, membranous urethral length, thickness of 
the levator ani muscle and urogenital diaphragm, 
higher pre-operative IPSS, type of urinary sphinc-
ter complex reconstruction, comorbidity score, 
among others, so that is a possible limitation of 
the model. Also, we did not use validated ques-
tionnaires for continence evaluation, although the 
number of pads/day is a broadly used variable, 
and the result of 78.3% of patients using no pads 
at 6 months represents a consistent finding consi-
dering an initial experience series.
 Apart from these challenges and limitations, 
this was a prospective study with strict follow-up. 
Our main results are comparable to the literature, 
and reflect the experience and results starting from 
the very first case performed in a public training 
hospital. We believe that these results are relevant 
for other centers initiating their urologic robotic 
program. Our next goal is to compare these outco-
mes and other variables together with our open ra-
dical prostatectomy cases, and these data are being 
gathered for next publications.
cOncLusIOns
 Our data indicate that, during early expe-
rience with RARP in a public academic hospital, 
it is possible to achieve good continence results 
with low rates of bleeding and complications rela-
ted to vesicourethral anastomosis. We also found 
that age and pathological staging was associated 
to early continence status.
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ABREvIATIOns
RP = radical prostatectomy
RARP = robotic assisted radical prostatectomy
VUA = vesicourethral anastomosis
PLND = pelvic lymph node dissection
RS = Rocco stitch
EBL = estimated blood loss
TRUS = transrectal ultrasound
PSA = prostatic specific antigen
BS = barbed sutures
Compliance with Ethical Standards:
Funding: The suture material (V-loc™) was 
donated by Covidien.
Ethical approval:
All procedures performed in studies invol-
ving human participants were in accordance with 
the ethical standards of the institutional and/or 
national research committee and with the 1964 
Helsinki declaration and its later amendments or 
comparable ethical standards.
Informed consent:
Informed consent was obtained from all 
individual participants included in the study.
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